Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant
Author:
Affiliation:
1. Division of Hematology and Internal Medicine; Mayo Clinic; Rochester MN USA
2. Division of Hematology; Seoul National Hospital; Seoul Korea
Publisher
Wiley
Subject
Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12282/fullpdf
Reference28 articles.
1. Currents concepts on the immunopathology of amyloidosis;Bhat;Clin Rev Allergy Immunol,2010
2. Amyloidosis: review of 236 cases;Kyle;Medicine (Baltimore),1975
3. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway;Shi;Proc Natl Acad Sci U S A,2010
4. Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture;Sikkink;Cell Death Dis,2010
5. Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL;Palladini;Blood,2006
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Risk factors, treatments and outcomes of patients with light chain amyloidosis who relapse after autologous stem cell transplantation;Bone Marrow Transplantation;2023-12-26
2. Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation;Blood Cancer Journal;2022-04-11
3. Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update;Mayo Clinic Proceedings;2021-06
4. Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis;Blood Cancer Journal;2021-01
5. Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis;Blood Cancer Journal;2020-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3